These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

650 related articles for article (PubMed ID: 25994217)

  • 1. Stromal biology and therapy in pancreatic cancer: a changing paradigm.
    Neesse A; Algül H; Tuveson DA; Gress TM
    Gut; 2015 Sep; 64(9):1476-84. PubMed ID: 25994217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stromal biology and therapy in pancreatic cancer.
    Neesse A; Michl P; Frese KK; Feig C; Cook N; Jacobetz MA; Lolkema MP; Buchholz M; Olive KP; Gress TM; Tuveson DA
    Gut; 2011 Jun; 60(6):861-8. PubMed ID: 20966025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stromal biology and therapy in pancreatic cancer: ready for clinical translation?
    Neesse A; Bauer CA; Öhlund D; Lauth M; Buchholz M; Michl P; Tuveson DA; Gress TM
    Gut; 2019 Jan; 68(1):159-171. PubMed ID: 30177543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stroma and pancreatic ductal adenocarcinoma: an interaction loop.
    Luo G; Long J; Zhang B; Liu C; Xu J; Ni Q; Yu X
    Biochim Biophys Acta; 2012 Aug; 1826(1):170-8. PubMed ID: 22521638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current and emerging therapies for patients with advanced pancreatic ductal adenocarcinoma: a bright future.
    Christenson ES; Jaffee E; Azad NS
    Lancet Oncol; 2020 Mar; 21(3):e135-e145. PubMed ID: 32135117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting the tumor microenvironment for pancreatic ductal adenocarcinoma therapy.
    Zhang YF; Jiang SH; Hu LP; Huang PQ; Wang X; Li J; Zhang XL; Nie HZ; Zhang ZG
    Chin Clin Oncol; 2019 Apr; 8(2):18. PubMed ID: 31070038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of stroma in pancreatic cancer: diagnostic and therapeutic implications.
    Erkan M; Hausmann S; Michalski CW; Fingerle AA; Dobritz M; Kleeff J; Friess H
    Nat Rev Gastroenterol Hepatol; 2012 Aug; 9(8):454-67. PubMed ID: 22710569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antifibrotic Therapy Disrupts Stromal Barriers and Modulates the Immune Landscape in Pancreatic Ductal Adenocarcinoma.
    Elahi-Gedwillo KY; Carlson M; Zettervall J; Provenzano PP
    Cancer Res; 2019 Jan; 79(2):372-386. PubMed ID: 30401713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Organotypic slice cultures of pancreatic ductal adenocarcinoma preserve the tumor microenvironment and provide a platform for drug response.
    Lim CY; Chang JH; Lee WS; Lee KM; Yoon YC; Kim J; Park IY
    Pancreatology; 2018 Dec; 18(8):913-927. PubMed ID: 30292644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamic Contrast-enhanced MRI Detects Responses to Stroma-directed Therapy in Mouse Models of Pancreatic Ductal Adenocarcinoma.
    Cao J; Pickup S; Clendenin C; Blouw B; Choi H; Kang D; Rosen M; O'Dwyer PJ; Zhou R
    Clin Cancer Res; 2019 Apr; 25(7):2314-2322. PubMed ID: 30587546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic cancer stroma: understanding biology leads to new therapeutic strategies.
    Rucki AA; Zheng L
    World J Gastroenterol; 2014 Mar; 20(9):2237-46. PubMed ID: 24605023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin D receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy.
    Sherman MH; Yu RT; Engle DD; Ding N; Atkins AR; Tiriac H; Collisson EA; Connor F; Van Dyke T; Kozlov S; Martin P; Tseng TW; Dawson DW; Donahue TR; Masamune A; Shimosegawa T; Apte MV; Wilson JS; Ng B; Lau SL; Gunton JE; Wahl GM; Hunter T; Drebin JA; O'Dwyer PJ; Liddle C; Tuveson DA; Downes M; Evans RM
    Cell; 2014 Sep; 159(1):80-93. PubMed ID: 25259922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of nano engineered approaches to overcome the stromal barrier in pancreatic cancer.
    Meng H; Nel AE
    Adv Drug Deliv Rev; 2018 May; 130():50-57. PubMed ID: 29958925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pancreatic stellate cells and pancreas cancer: current perspectives and future strategies.
    Haqq J; Howells LM; Garcea G; Metcalfe MS; Steward WP; Dennison AR
    Eur J Cancer; 2014 Oct; 50(15):2570-82. PubMed ID: 25091797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD10+ pancreatic stellate cells enhance the progression of pancreatic cancer.
    Ikenaga N; Ohuchida K; Mizumoto K; Cui L; Kayashima T; Morimatsu K; Moriyama T; Nakata K; Fujita H; Tanaka M
    Gastroenterology; 2010 Sep; 139(3):1041-51, 1051.e1-8. PubMed ID: 20685603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyaluronan, fluid pressure, and stromal resistance in pancreas cancer.
    Provenzano PP; Hingorani SR
    Br J Cancer; 2013 Jan; 108(1):1-8. PubMed ID: 23299539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-stromal crosstalk in pancreatic cancer and tissue fibrosis.
    Thomas D; Radhakrishnan P
    Mol Cancer; 2019 Jan; 18(1):14. PubMed ID: 30665410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pancreas cancer microenvironment.
    Feig C; Gopinathan A; Neesse A; Chan DS; Cook N; Tuveson DA
    Clin Cancer Res; 2012 Aug; 18(16):4266-76. PubMed ID: 22896693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biology and clinical applications of pancreatic cancer stem cells.
    Abel EV; Simeone DM
    Gastroenterology; 2013 Jun; 144(6):1241-8. PubMed ID: 23622133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The conflicting roles of tumor stroma in pancreatic cancer and their contribution to the failure of clinical trials: a systematic review and critical appraisal.
    Bijlsma MF; van Laarhoven HW
    Cancer Metastasis Rev; 2015 Mar; 34(1):97-114. PubMed ID: 25566685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.